Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000861780 | SCV000533385 | likely benign | not provided | 2020-03-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000861780 | SCV001002180 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022471 | SCV002756296 | likely benign | not specified | 2022-04-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000861780 | SCV004158540 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | ELP1: BP4, BP7 |
Breakthrough Genomics, |
RCV000861780 | SCV005224848 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001276231 | SCV001462231 | uncertain significance | Familial dysautonomia | 2020-01-17 | no assertion criteria provided | clinical testing |